Clinical Trial Update: Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety and efficacy of an oral immunomodulator in tuberculosis and TB/HIV patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Oral immunomodulator

Snippet

Sponsor: Lisichansk Regional Tuberculosis Dispensary | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED